Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02030197 · ClinicalTrials.gov registry record · NA
Impact of CRISP on Self-Efficacy, Loneliness, and Depression
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT02030197 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 118 participants.
The verdict
NCT02030197, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of an innovative program, entitled CRISP (Community Integration for Socially Isolated Patients), on improving self-efficacy and assessing whether improved self-efficacy helps to reduce depression and loneliness of people with MS.
Interventions
- OTHER Control Group
- BEHAVIORAL CRISP Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02030197
The ClinicalTrials.gov registry entry for NCT02030197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT02030197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02030197 about?
NCT02030197 is a clinical study titled "Impact of CRISP on Self-Efficacy, Loneliness, and Depression". The purpose of this study is to examine the effects of an innovative program, entitled CRISP (Community Integration for Socially Isolated Patients), on improving self-efficacy and assessing whether improved self-efficacy helps to reduce depression and loneliness of people with MS.
What is the current status of trial NCT02030197?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2014-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02030197?
The interventions under investigation include: Control Group (OTHER), CRISP Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02030197?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.